Model could support the assessment of long-term chronic drug therapies and help clinicians develop more effective treatments for complex diseases
Using artificial intelligence, a team of University at Buffalo researchers has developed a novel system that models the progression of chronic diseases as patients age.
Published in Oct. in the Journal of Pharmacokinetics and Pharmacodynamics, the model assesses metabolic and cardiovascular biomarkers – measurable biological processes such as cholesterol levels, body mass index, glucose and blood pressure – to calculate health status and disease risks across a patient’s lifespan.
The findings are critical due to the increased risk of developing metabolic and cardiovascular diseases with aging, a process that has adverse effects on cellular, psychological and behavioral processes.
“There is an unmet need for scalable approaches that can provide guidance for pharmaceutical care across the lifespan in the presence of aging and chronic co-morbidities,” says lead author Murali Ramanathan, PhD, professor of pharmaceutical sciences in the UB School of Pharmacy and Pharmaceutical Sciences. “This knowledge gap may be potentially bridged by innovative disease progression modeling.”
The model could facilitate the assessment of long-term chronic drug therapies, and help clinicians monitor treatment responses for conditions such as diabetes, high cholesterol and high blood pressure, which become more frequent with age, says Ramanathan.
Additional investigators include first author and UB School of Pharmacy and Pharmaceutical Sciences alumnus Mason McComb, PhD; Rachael Hageman Blair, PhD, associate professor of biostatistics in the UB School of Public Health and Health Professions; and Martin Lysy, PhD, associate professor of statistics and actuarial science at the University of Waterloo.
The research examined data from three case studies within the third National Health and Nutrition Examination Survey (NHANES) that assessed the metabolic and cardiovascular biomarkers of nearly 40,000 people in the United States.
Biomarkers, which also include measurements such as temperature, body weight and height, are used to diagnose, treat and monitor overall health and numerous diseases.
The researchers examined seven metabolic biomarkers: body mass index, waist-to-hip ratio, total cholesterol, high-density lipoprotein cholesterol, triglycerides, glucose and glycohemoglobin. The cardiovascular biomarkers examined include systolic and diastolic blood pressure, pulse rate and homocysteine.
By analyzing changes in metabolic and cardiovascular biomarkers, the model “learns” how aging affects these measurements. With machine learning, the system uses a memory of previous biomarker levels to predict future measurements, which ultimately reveal how metabolic and cardiovascular diseases progress over time.
Original Article: AI-powered computer model predicts disease progression during aging
More from: University at Buffalo | University of Waterloo
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Long-term chronic drug therapies
- Long-Term Medical Marijuana Use Tied To Reduced Opioid Dosages, American Medical Association-Published Study Shows
A new study, led by researchers at New York’s Department of Health and published this week by the American Medical Association, found that chronic pain patients who received medical marijuana for ...
- Antidepressants mostly can't treat chronic pain, despite wide use
Ongoing pain, such as chronic back or neck pain, is difficult to treat, so some doctors prescribe antidepressants. Now, a review of evidence says these drugs mostly don't work as a treatment ...
- Medical cannabis for chronic pain may help patients on long-term opioid treatment reduce dosages
A new study from New York State and CUNY researchers suggests that receiving medical cannabis for thirty days or more may help patients on long-term opioid treatment to lower their dose over time.
- Is it safe to take the anti-obesity drug Wegovy long-term? Doctors weigh in
“This supports the belief that obesity is a chronic disease that requires ... for which most patients remain on therapy long term in order to continue to experience the benefits of their medications.” ...
- Weight-loss drug Wegovy only works when you take it. Is it safe for the long term?
How long can you stay on Wegovy or Ozempic for weight loss? Doctors explain why the drug semaglutide needs to be taken for the long term and if it's safe.
Go deeper with Google Headlines on:
Long-term chronic drug therapies
[google_news title=”” keyword=”long-term chronic drug therapies” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Progression of chronic diseases
- If you have high blood pressure or diabetes, it's essential to get regular testing for chronic kidney disease
Your treatment options generally depend on the underlying cause of kidney disease and the severity of the damage to your kidneys. In the later stages of chronic kidney disease, when your kidneys stop ...
- How to slow the progression of chronic kidney disease
Chronic kidney disease is common in the U.S. The most common risk factors are diabetes and high blood pressure. Diet and exercise can slow the progression.
- Chronic Kidney Disease Drugs Market 2023: Top Manufacturers, Key Trends, Progression Status and Business Trends and forecast to 2028
The “Chronic Kidney Disease Drugs Market” report provides an in-depth analysis of the size of the global market. It ...
- What to know about the stages of chronic lymphocytic leukemia
Chronic lymphocytic leukemia (CLL ... Both systems take into account certain markers of disease progression, such as lymph node enlargement, anemia, and thrombocytopenia. Doctors in the U.S ...
- Epidemiology and Survival of the Five Stages of Chronic Kidney Disease in a Systolic Heart Failure Population
Aims The epidemiology of the five stages of chronic kidney disease (CKD) in systolic heart failure (HF) patients has predominantly been described in hospitalized White patients, with little known ...
Go deeper with Google Headlines on:
Progression of chronic diseases
[google_news title=”” keyword=”progression of chronic diseases” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
